Fundz

Who to call at Illimis Therapeutics, and when

Fundz watches for the moments Illimis Therapeutics starts buying, and tells you who to reach.

  • An alert the day Illimis Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Illimis Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Illimis Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Ilimis Therapeutics forms partnership with Lilly to enhance development of GAIA-based Alzheimer's therapies.

Jul 16, 2025

Contract Type

partnership

SeoulBiotechnologyHealth CareTherapeutics

Description

Ilimis Therapeutics has entered into a partnership with Lilly Catalyze360 to accelerate the development of its GAIA platform for Alzheimer's disease drugs. This collaboration will also support the expansion of drug indications and the pursuit of early-stage collaborations with global pharmaceutical companies.

Company Information

Company

Illimis Therapeutics

Location

Seoul, Seoul, South Korea

About

Illimis Therapeutics is a biotechnology company focused on developing therapeutics for CNS and immune diseases using its innovative GAIA platform. The company aims to create next-generation treatment options for neuro-immune diseases, addressing high unmet medical needs. Illimis actively engages in partnerships with global pharmaceutical companies and research institutions to enhance its drug development capabilities. It has secured various funding and collaborations to advance its research and development efforts.

Related People

Sanghoon
Likely contact at this company
••••••••@••••••••

See Sanghoon's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Illimis Therapeutics's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Illimis Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.